What’s involved?
Photographer : Huang Zhu
Thankyou for supporting the Novartis campaign
Swiss pharmaceutical company Novartis took the Indian Government to court over its patent law. India has long been an important source of affordable essential medicines because the country did not grant pharmaceutical patents until 2005. Generic antiretroviral medicines produced in India are used to treat over 80% of the 80,000 people that receive treatment today in MSF’s AIDS projects in more than 30 countries.
Novartis has lost its case against the Indian Government. The MSF Drop the Case petition collected over 420,000 signatures. "Thanks to our supporters, MSF continues to work towards affordable drugs for those in real need".
“The High Court’s decision to uphold the Patents Act means that our patients can continue to rely on India as a source of affordable medicines: therefore thousands of men, women and children can continue their treatment in developing countries" - Philippe Couturier, Executive Director MSF Australia.
I want to do this!
This work is licenced under an Attribution-NoDerivs licence.
© 2008. First published on actnow.com.au
Tell me about creative commons licences
